Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach

L Lai, TC Leone, MP Keller, OJ Martin… - Circulation: Heart …, 2014 - Am Heart Assoc
L Lai, TC Leone, MP Keller, OJ Martin, AT Broman, J Nigro, K Kapoor, TR Koves, R Stevens
Circulation: Heart Failure, 2014Am Heart Assoc
Background—An unbiased systems approach was used to define energy metabolic events
that occur during the pathological cardiac remodeling en route to heart failure (HF). Methods
and Results—Combined myocardial transcriptomic and metabolomic profiling were
conducted in a well-defined mouse model of HF that allows comparative assessment of
compensated and decompensated (HF) forms of cardiac hypertrophy because of pressure
overload. The pressure overload data sets were also compared with the myocardial …
Background
An unbiased systems approach was used to define energy metabolic events that occur during the pathological cardiac remodeling en route to heart failure (HF).
Methods and Results
Combined myocardial transcriptomic and metabolomic profiling were conducted in a well-defined mouse model of HF that allows comparative assessment of compensated and decompensated (HF) forms of cardiac hypertrophy because of pressure overload. The pressure overload data sets were also compared with the myocardial transcriptome and metabolome for an adaptive (physiological) form of cardiac hypertrophy because of endurance exercise training. Comparative analysis of the data sets led to the following conclusions: (1) expression of most genes involved in mitochondrial energy transduction were not significantly changed in the hypertrophied or failing heart, with the notable exception of a progressive downregulation of transcripts encoding proteins and enzymes involved in myocyte fatty acid transport and oxidation during the development of HF; (2) tissue metabolite profiles were more broadly regulated than corresponding metabolic gene regulatory changes, suggesting significant regulation at the post-transcriptional level; (3) metabolomic signatures distinguished pathological and physiological forms of cardiac hypertrophy and served as robust markers for the onset of HF; and (4) the pattern of metabolite derangements in the failing heart suggests bottlenecks of carbon substrate flux into the Krebs cycle.
Conclusions
Mitochondrial energy metabolic derangements that occur during the early development of pressure overload–induced HF involve both transcriptional and post-transcriptional events. A subset of the myocardial metabolomic profile robustly distinguished pathological and physiological cardiac remodeling.
Am Heart Assoc